New data presented at the American Society of Retina Specialists 2024 examine the benefits and adverse event profiles of two ...

Age-related macular degeneration (ARMD) is the leading cause of severe vision loss in the developed world for people over 55 ...

Eating two ounces of unsalted pistachios daily for 12 days significantly improved the health of macular pigment optical ...

Current treatments sometimes fail to help people with "wet" age-related macular degeneration-- and researchers now think they ...

An RNA-editing gene therapy has been developed that switches off the key driver of common eye conditions affecting diabetics ...

A new study explains not only why some patients with wet age-related macular degeneration (or 'wet' AMD) fail to have vision improvement with treatment, but also how an experimental drug could be used ...

Sandoz's approval of Afqlir highlights their commitment to affordable, effective treatment options for retinal diseases.

MEDIA RELEASEAfqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD)One ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

Sandoz (SDZNY) said that the European Commission has granted marketing authorization for Afqlir (aflibercept) 2 mg vial kit and ...